Glaucoma Research Foundation Announces $2.5 Million in Grants to Cure Glaucoma
14 Mar 2024
SAN FRANCISCO, March 14, 2024 /PRNewswire/ -- Glaucoma Research Foundation (GRF) today announced a total of $2.5 million in annual research grants to support innovative research to cure glaucoma and restore vision. Grants were awarded to 18 investigators at prominent universities in the United States, Nigeria, and Hong Kong.
Continue Reading
"This is the largest annual research budget in our 46-year history, said
Thomas M. Brunner, GRF President and CEO. It's the first time we've had two Catalyst for a Cure initiatives running concurrently plus the greatest number of Shaffer Research Grants we have funded in a single year. Brunner added, "The Vision Restoration Initiative and the Initiative to Prevent and Cure Neurodegeneration are making new discoveries bringing us closer to a cure for glaucoma."
"This is the largest annual research budget in our 46-year history," said Thomas M. Brunner, GRF President and CEO.
Post this
Glaucoma Research Foundation is awarding $1 million to the Catalyst for a Cure Vision Restoration Initiative principal investigators to continue their promising research toward restoring vision in glaucoma, and $800,000 to the Catalyst for a Cure Initiative to Prevent and Cure Neurodegeneration. Ten one-year, $55,000 Shaffer Grants will be awarded to support research into glaucoma genetics and new treatment for glaucoma.
"In August we'll bring together scientists we fund with some of the brightest scientific minds in vision research for our annual Catalyst Meeting in Boston," said
Andrew G. Iwach, MD, GRF Board Chair. "GRF is doing our best to invest in research that brings us closer to our goal of curing glaucoma and restoring vision, while at the same time developing better solutions for patients today."
Catalyst for a Cure Research Collaboration
Principal investigators:
Xin Duan, PhD, UC San Francisco;
Yang Hu, MD, PhD, Stanford;
Anna La Torre, PhD, UC Davis; and
Derek Welsbie, MD, PhD, UC San Diego;
Sandro Da Mesquita, PhD, Mayo Clinic;
Milica Margeta, MD, PhD, Mass Eye and Ear;
Karthik Shekhar, PhD, UC Berkeley; and
Humsa Venkatesh, PhD, Harvard.
The 2024 Shaffer Grants for Innovative Glaucoma Research
Revathi Balasubramanian, PhD
Kevin Chan, PhD
Bryce Chiang, MD, PhD
Cátia Gomes, PhD
Meredith Gregory-Ksander, PhD
Mass Eye and Ear, Harvard
Takaaki Kuwajima, PhD
Margaret MacNeil, PhD
York College, CUNY
Felipe
Medeiros, MD, PhD
Olusola
Olawoye,
MD, PhD
Samantha Sze Wan Shan, PhD
About Glaucoma Research Foundation.
SOURCE Glaucoma Research Foundation
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.